33.71
price up icon2.43%   0.80
after-market Dopo l'orario di chiusura: 33.99 0.28 +0.83%
loading

Viking Therapeutics Inc Azioni (VKTX) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
16.35%
34.07
29.29 27.27 23.74 20.54
Operating Income/Loss
16.35%
-34.07
-29.29 -27.27 -23.74 -20.54
Income/Loss From Continuing Operations Before Tax
11.19%
-27.36
-24.60 -22.53 -19.23 -19.53
Income/Loss From Continuing Operations After Tax
11.18%
-27.36
-24.61 -22.53 -19.23 -19.53
Net Income/Loss
11.18%
-27.36
-24.61 -22.53 -19.23 -19.53
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
5,444%
103.46
1.866 99.85 99.01 78.35
Diluted Average Shares
5,444%
103.46
1.866 99.85 99.01 78.35
Basic Earnings Per Share
4.00%
-0.26
-0.25 -0.23 -0.19 -0.25
Diluted Earnings Per Share
4.00%
-0.26
-0.25 -0.23 -0.19 -0.25
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$77.55
price up icon 0.23%
$37.12
price down icon 0.40%
$105.18
price up icon 0.17%
$26.66
price down icon 0.30%
$110.05
price down icon 1.28%
biotechnology ONC
$299.94
price down icon 1.90%
Capitalizzazione:     |  Volume (24 ore):